Alkermes (ALKS) Shares Outstanding (2010 - 2026)

Alkermes' (ALKS) quarterly Shares Outstanding (Entity) came in at $183.6 million in Q1 2026, up 1.89% year-on-year from $180.2 million in Q1 2025, and up 1.43% on a QoQ basis from $181.0 million in Q4 2025.

Alkermes (ALKS) Shares Outstanding (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Shares Outstanding (Entity) data on file, last reported at $183.6 million in Q1 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 1.89% year-over-year to $183.6 million in Q1 2026; TTM through Mar 2026 was $183.6 million, a 1.89% increase from a year earlier, with the FY2025 full-year figure at $181.0 million, up 2.46% from the prior year.
  • Shares Outstanding (Entity) for Q1 2026 stood at $183.6 million, up from $181.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for ALKS reached as high as $183.6 million in Q1 2026 and fell as low as $167.7 million in Q1 2022.
  • Historically, Shares Outstanding (Entity) has averaged $174.9 million across 5 years, with a median of $175.7 million in 2024.
  • Across the five-year window, Shares Outstanding (Entity) rose 1.89% in 2023 and increased 2.55% in 2025, its largest moves.
  • Year by year, Shares Outstanding (Entity) stood at $169.0 million in 2022, then climbed by 2.14% to $172.6 million in 2023, then rose by 2.38% to $176.7 million in 2024, then increased by 2.46% to $181.0 million in 2025, then grew by 1.43% to $183.6 million in 2026.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $183.6 million in Q1 2026, $181.0 million in Q4 2025, and $180.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 43.50 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 31.59 Bn
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 497.70 Mn
10 Alkermes 8.78 Bn 8.27 Bn 331.33 Mn 166.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 166.20 Mn
Dec 31, 2025 164.70 Mn
Sep 30, 2025 165.09 Mn
Jun 30, 2025 164.96 Mn
Mar 31, 2025 163.41 Mn
Dec 31, 2024 165.39 Mn
Sep 30, 2024 163.37 Mn
Jun 30, 2024 168.32 Mn
Mar 31, 2024 167.98 Mn
Dec 31, 2023 166.22 Mn
Sep 30, 2023 166.61 Mn
Jun 30, 2023 166.28 Mn
Mar 31, 2023 165.09 Mn
Dec 31, 2022 163.54 Mn
Sep 30, 2022 164.28 Mn
Jun 30, 2022 163.84 Mn
Mar 31, 2022 162.48 Mn
Dec 31, 2021 160.94 Mn
Sep 30, 2021 161.46 Mn
Jun 30, 2021 160.82 Mn